Loading...
Market
What will be the revenue impact on Siemens Healthineers by the end of 2025 due to the acquisition of Novartis' Molecular Imaging Business?
2
Resolution / Starting Odds
Increase by more than 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
No significant increase • 25%
Siemens Healthineers' annual financial reports or major financial news outlets
Story
Siemens Healthineers to Acquire Novartis' Molecular Imaging Business in $224 Million Deal
Aug 26, 2024, 12:36 PM
Siemens Healthineers has agreed to acquire a part of Novartis' business specializing in radioactive chemicals used for cancer scans. The $224 million deal involves the molecular imaging business for Fluorine-18 positron emission tomography (PET) scans. This acquisition is expected to further boost Siemens Healthineers' healthcare operations. Novartis confirmed receiving a binding offer from Siemens Healthineers for this acquisition.
View original story
Similar markets
Revenue decrease due to MRT-6160 • 25%
Revenue increase due to MRT-6160 • 25%
No significant financial impact • 25%
MRT-6160 discontinued • 25%
Increase by more than 5% • 25%
Increase by up to 5% • 25%
Decrease by up to 5% • 25%
Decrease by more than 5% • 25%
Increase by 5% or more • 33%
Fluctuate within ±5% • 33%
Decrease by 5% or more • 33%
Less than $10 million • 25%
$10 million - $50 million • 25%
$50 million - $100 million • 25%
More than $100 million • 25%
Significant growth (>10%) • 25%
Moderate growth (5-10%) • 25%
Minimal growth (<5%) • 25%
No growth or decline • 25%
Less than $140 million • 33%
$140 million - $500 million • 33%
More than $500 million • 33%
Less than $50 million • 25%
$50 million to $100 million • 25%
$100 million to $200 million • 25%
More than $200 million • 25%
Growth above 10% • 25%
Growth 5-10% • 25%
Growth below 5% • 25%
No growth • 25%
Increase by more than 10% • 25%
Increase by up to 10% • 25%
No significant change • 25%
Decrease • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than $500 million • 25%
$500 million to $1 billion • 25%
$1 billion to $2 billion • 25%
More than $2 billion • 25%
